Cargando…
Bivalirudin and post-cardiotomy ECMO: a word of caution
Bivalirudin has been proposed as the sole anticoagulant in patients under extracorporeal membrane oxygenation (ECMO) or cardiopulmonary bypass. Owing to the pharmacodynamic properties of bivalirudin, areas of blood stagnation should be carefully avoided in order to limit the risk of thrombosis. The...
Autor principal: | Ranucci, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580606/ https://www.ncbi.nlm.nih.gov/pubmed/22574927 http://dx.doi.org/10.1186/cc11314 |
Ejemplares similares
-
Angiotensin II in ECMO patients: a word of caution
por: Antonucci, Elio, et al.
Publicado: (2019) -
COVID-19, ECMO, and lymphopenia: a word of caution
por: Henry, Brandon Michael
Publicado: (2020) -
Is it time to switch to bivalirudin for ECMO anticoagulation?
por: Navaei, Amir, et al.
Publicado: (2023) -
A word of caution
por: Arolkar, Satish
Publicado: (2015) -
A word of caution
por: Gupta, Neelesh, et al.
Publicado: (2020)